Skip to main content
Top
Published in: Tumor Biology 3/2014

01-03-2014 | Research Article

Polymorphisms in ESR1 and FLJ43663 are associated with breast cancer risk in the Han population

Authors: Peng Xia, Tianbo Jin, Tingting Geng, Ting Sun, Xiaolan Li, Chengxue Dang, Longli Kang, Chao Chen, Jiying Sun

Published in: Tumor Biology | Issue 3/2014

Login to get access

Abstract

Breast cancer is a heterogeneous disease which is influenced by genetic, environmental, and lifestyle factors. Genetic susceptibility is likely to be due to variants conferring more moderate risks. To identify susceptibility alleles, we conducted a case–control association study in 185 breast cancer cases and 199 controls in the Han population. We genotyped 14 tagging single nucleotide polymorphisms previously implicated in breast cancer using Sequenom MassARRAY SNP genotyping method and identified rs3734805 in the ESR1 gene and rs2048672 in the FLJ43663 gene were associated with breast cancer risk. Allele “C” of rs3734805 was associated with increased breast cancer progression by χ 2 test and additive model analysis (OR = 1.36; 95 % CI, 1.01–1.82; p = 0.042). Using recessive model analysis, we found that genotype “GG” of rs2048672 was the protective genotype during breast cancer progression (OR = 0.55; 95 % CI, 0.32–0.95; p = 0.029). Our results provide additional insights into the opposing roles of the ESR1 and FLJ43663 genes in breast cancer onset and progression.
Literature
2.
go back to reference Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, et al. Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2009;18:1610–6.PubMedCentralPubMedCrossRef Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, et al. Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2009;18:1610–6.PubMedCentralPubMedCrossRef
3.
go back to reference Sehrawat B, Sridharan M, Ghosh S, Robson P, Cass CE, Mackey JR, et al. Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility. Hum Genet. 2011;130:529–37.PubMedCentralPubMedCrossRef Sehrawat B, Sridharan M, Ghosh S, Robson P, Cass CE, Mackey JR, et al. Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility. Hum Genet. 2011;130:529–37.PubMedCentralPubMedCrossRef
4.
go back to reference Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009;41:324–8.PubMedCentralPubMedCrossRef Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009;41:324–8.PubMedCentralPubMedCrossRef
5.
go back to reference Sapkota Y, Yasui Y, Lai R, Sridharan M, Robson PJ, Cass CE, et al. Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm. Plos One. 2013;8(5):e62550.PubMedCentralPubMedCrossRef Sapkota Y, Yasui Y, Lai R, Sridharan M, Robson PJ, Cass CE, et al. Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm. Plos One. 2013;8(5):e62550.PubMedCentralPubMedCrossRef
6.
go back to reference Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42:504–7.PubMedCentralPubMedCrossRef Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42:504–7.PubMedCentralPubMedCrossRef
7.
go back to reference Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A. 2008;105:4340–5.PubMedCentralPubMedCrossRef Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A. 2008;105:4340–5.PubMedCentralPubMedCrossRef
8.
go back to reference Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39:347–51.PubMedCrossRef Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39:347–51.PubMedCrossRef
10.
go back to reference Adamec C. Example of the use of the nonparametric test. Test X2 for comparison of 2 independent examples. Cesk Zdrav. 1964;12:613–9.PubMed Adamec C. Example of the use of the nonparametric test. Test X2 for comparison of 2 independent examples. Cesk Zdrav. 1964;12:613–9.PubMed
12.
go back to reference Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22:1928–9.PubMedCrossRef Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22:1928–9.PubMedCrossRef
14.
go back to reference Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst. 2011;103:425–35.PubMedCrossRef Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst. 2011;103:425–35.PubMedCrossRef
15.
go back to reference Yue W, Wang JP, Li Y, Bocchinfuso WP, Korach KS, Devanesan PD, et al. Tamoxifen versus aromatase inhibitors for breast cancer prevention. Clin Cancer Res. 2005;11:925s–30s.PubMed Yue W, Wang JP, Li Y, Bocchinfuso WP, Korach KS, Devanesan PD, et al. Tamoxifen versus aromatase inhibitors for breast cancer prevention. Clin Cancer Res. 2005;11:925s–30s.PubMed
16.
go back to reference Cai Q, Long J, Lu W, Qu S, Wen W, Kang D, et al. Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet. 2011;20:4991–9.PubMedCentralPubMedCrossRef Cai Q, Long J, Lu W, Qu S, Wen W, Kang D, et al. Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet. 2011;20:4991–9.PubMedCentralPubMedCrossRef
Metadata
Title
Polymorphisms in ESR1 and FLJ43663 are associated with breast cancer risk in the Han population
Authors
Peng Xia
Tianbo Jin
Tingting Geng
Ting Sun
Xiaolan Li
Chengxue Dang
Longli Kang
Chao Chen
Jiying Sun
Publication date
01-03-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 3/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1289-7

Other articles of this Issue 3/2014

Tumor Biology 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine